Last reviewed · How we verify
NCT05524623
Comparative Effect of MEP With or Without Current Emission in the Treatment of Cervical Pain in MTrPs of the Trapezius
NA trial testing percutaneous microelectrolysis in myofascial trigger points of the trapezius in Neck Pain, Posterior in 95 participants. Completed in 30 March 2023.
30 November 2022
Quick facts
| Lead sponsor | Universidad Nacional de Córdoba |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 95 |
| Start date | 16 August 2022 |
| Primary completion | 30 November 2022 |
| Estimated completion | 30 March 2023 |
| Sites | 1 location across Argentina |
Drugs / interventions tested
- percutaneous microelectrolysis in myofascial trigger points of the trapezius
Conditions studied
- Neck Pain, Posterior — all drugs for Neck Pain, Posterior →
- Myofascial Pain Syndromes — all drugs for Myofascial Pain Syndromes →
Sponsor
Universidad Nacional de Córdoba
Who can join
Adults 20 to 60, any sex, with Neck Pain, Posterior or Myofascial Pain Syndromes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Myofascial pain syndrome (MPS) is initial to other pathologies such as neck pain or tension headaches; the symptoms that are located on the area of myofascial trigger points (MTrPs) of specific references in different muscles. MTrPs are palpable, tense bands found in stiff muscle that cause pain and swelling. They affect the disruptive soft tissues, resulting in deterioration of the muscle and fascia; effects that can be transferred further, through the myofascial chain to distant tissues, inducing the referred pain that is the main feature of MPS. MTrPs are treated with stretching, massage, analgesics, acupuncture, dry needling, electrical stimulation, and ultrasound. Percutaneous microelectrolysis (MEP®) is a new technique that uses galvanic current of low intensity and high density. Based on the previous reviews, the investigators consider that the use of MEP in individuals who have MTrPs in the trapezius is more effective than acupuncture treatment. Objectives: To assess the effect of MEP as a technique for treating pain in MTrPs of the trapezius muscle compared to without current emission, analyzing function, pain and strength in MTrPs before and after both treatments.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05524623
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neck Pain, Posterior
Currently open trials in the same condition.
- NCT05617365 — Treating Chronic Cervicogenic Head and Neck Pain · Phase 1, PHASE2 · recruiting
Other Universidad Nacional de Córdoba trials
Trials by the same sponsor.
- NCT04050813 — Efficacy of Flywheel Inertial Resistance Training in the Architecture and Function of the Hamstring · NA · completed
- NCT03917849 — Efficacy of Inertial Flywheel vs Heavy Slow Resistance Training Among Athletes With Patellar Tendinopathy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05524623 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Nacional de Córdoba
- Last refreshed: 19 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05524623.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing